Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) had its target price raised by equities researchers at Piper Sandler from $13.00 to $18.00 in a report issued on Thursday, Marketbeat.com reports. The firm presently has an “overweight” rating on the stock. Piper Sandler’s target price would indicate a potential upside of 23.71% from the stock’s previous […]
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued ratings on the stock in the […]
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) saw some unusual options trading activity on Monday. Stock investors bought 4,167 call options on the stock. This represents an increase of 86% compared to the typical daily volume of 2,236 call options. Wall Street Analyst Weigh In A number of brokerages have commented on AVDL. Oppenheimer […]
By extending inter-company loans, VRL can address outstanding external debt requirements, including a $1bn bond due in January 2024. The move could also enable VRL to borrow $2.4bn, upfront, using brand fee receivables to repay outstanding debt obligations.
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) saw a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 3,720,000 shares, a decline of 21.4% from the June 15th total of 4,730,000 shares. Based on an average daily volume of 971,200 shares, the short-interest ratio […]